Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Neurosci ; 36(10): 2881-93, 2016 Mar 09.
Article in English | MEDLINE | ID: mdl-26961944

ABSTRACT

Perinatal stroke leads to significant morbidity and long-term neurological and cognitive deficits. The pathophysiological mechanisms of brain damage depend on brain maturation at the time of stroke. To understand whether microglial cells limit injury after neonatal stroke by preserving neurovascular integrity, we subjected postnatal day 7 (P7) rats depleted of microglial cells, rats with inhibited microglial TGFbr2/ALK5 signaling, and corresponding controls, to transient middle cerebral artery occlusion (tMCAO). Microglial depletion by intracerebral injection of liposome-encapsulated clodronate at P5 significantly reduced vessel coverage and triggered hemorrhages in injured regions 24 h after tMCAO. Lack of microglia did not alter expression or intracellular redistribution of several tight junction proteins, did not affect degradation of collagen IV induced by the tMCAO, but altered cell types producing TGFß1 and the phosphorylation and intracellular distribution of SMAD2/3. Selective inhibition of TGFbr2/ALK5 signaling in microglia via intracerebral liposome-encapsulated SB-431542 delivery triggered hemorrhages after tMCAO, demonstrating that TGFß1/TGFbr2/ALK5 signaling in microglia protects from hemorrhages. Consistent with observations in neonatal rats, depletion of microglia before tMCAO in P9 Cx3cr1(GFP/+)/Ccr2(RFP/+) mice exacerbated injury and induced hemorrhages at 24 h. The effects were independent of infiltration of Ccr2(RFP/+) monocytes into injured regions. Cumulatively, in two species, we show that microglial cells protect neonatal brain from hemorrhage after acute ischemic stroke.


Subject(s)
Gene Expression Regulation, Developmental/genetics , Infarction, Middle Cerebral Artery/complications , Intracranial Hemorrhages/etiology , Intracranial Hemorrhages/prevention & control , Microglia/physiology , Age Factors , Animals , Animals, Newborn , Benzamides/pharmacology , Bone Density Conservation Agents/pharmacology , Caspase 3/metabolism , Clodronic Acid/toxicity , Dioxoles/pharmacology , Disease Models, Animal , Endothelial Cells/pathology , Female , Gene Expression Regulation, Developmental/drug effects , Male , Mice , Mice, Transgenic , Microglia/drug effects , Rats , Signal Transduction/drug effects , Signal Transduction/physiology , Smad2 Protein/metabolism , Transforming Growth Factor beta1/antagonists & inhibitors , Transforming Growth Factor beta1/metabolism
2.
Brain Res ; 1125(1): 155-62, 2006 Dec 13.
Article in English | MEDLINE | ID: mdl-17109833

ABSTRACT

Cerebrovascular complications including cerebral edema, raised intracranial pressure and hemorrhage contribute to the high mortality and morbidity of herpes-simplex virus encephalitis (HSE). We examined changes of collagen type IV, the major constituent of the neurovascular matrix, together with expression and localization of matrix-degrading enzymes during the development of acute HSE. In an experimental model of focal HSE, we found that early, symptomatic HSE (3 days after infection) and acute, fully developed HSE (7 days after infection) are associated with significantly raised levels of matrix-metalloproteinase-9 (MMP-9) (both P<0.05). In situ zymography of brain sections revealed that the increase of MMP-9 was restricted to the cerebral vasculature in early HSE and further expanded towards the perivascular space and adjacent tissue in acute HSE. Around the cerebral vasculature, we observed that MMP-9 activity was insufficiently counterbalanced by its endogenous tissue inhibitor of MMP (TIMP) TIMP-1, resulting in loss of collagen type IV. Our findings suggest that MMP-9 is involved in the evolution of HSE by causing damage to the cerebral vasculature. The degradation of the neurovascular matrix in HSE facilitates the development of cerebrovascular complications and may represent a target for novel adjuvant treatment strategies.


Subject(s)
Collagen Type IV/metabolism , Encephalitis, Herpes Simplex/metabolism , Encephalitis, Herpes Simplex/physiopathology , Gene Expression Regulation/physiology , Matrix Metalloproteinase 2/metabolism , Animals , Blotting, Western/methods , Collagen Type IV/genetics , Disease Models, Animal , Dose-Response Relationship, Immunologic , Electrophoresis, Polyacrylamide Gel/methods , Female , Immunohistochemistry/methods , In Situ Hybridization/methods , Matrix Metalloproteinase 2/genetics , Mice , Time Factors , Viral Load
3.
J Neuropathol Exp Neurol ; 63(6): 610-7, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15217089

ABSTRACT

Neurons of the hippocampal dentate gyrus selectively undergo programmed cell death in patients suffering from bacterial meningitis and in experimental models of pneumococcal meningitis in infant rats. In the present study, a membrane-based organotypic slice culture system of rat hippocampus was used to test whether this selective vulnerability of neurons of the dentate gyrus could be reproduced in vitro. Apoptosis was assessed by nuclear morphology (condensed and fragmented nuclei), by immunochemistry for active caspase-3 and deltaC-APP, and by proteolytic caspase-3 activity. Co-incubation of the cultures with live pneumococci did not induce neuronal apoptosis unless cultures were kept in partially nutrient-deprived medium. Complete nutrient deprivation alone and staurosporine independently induced significant apoptosis, the latter in a dose-response way. In all experimental settings, apoptosis occurred preferentially in the dentate gyrus. Our data demonstrate that factors released by pneumococci per se failed to induce significant apoptosis in vitro. Thus, these factors appear to contribute to a multifactorial pathway, which ultimately leads to neuronal apoptosis in bacterial meningitis.


Subject(s)
Apoptosis/physiology , Hippocampus/cytology , Neurons/cytology , Streptococcus pneumoniae , Animals , Caspase 3 , Caspases/metabolism , Culture Media/pharmacology , Hippocampus/drug effects , Hippocampus/enzymology , Hippocampus/microbiology , Immunohistochemistry , Meningitis, Bacterial/microbiology , Meningitis, Bacterial/pathology , Neurons/drug effects , Neurons/enzymology , Neurons/microbiology , Organ Culture Techniques , Rats , Rats, Wistar , Staurosporine/pharmacology , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/growth & development
4.
Int J Parasitol ; 32(5): 533-42, 2002 May.
Article in English | MEDLINE | ID: mdl-11943226

ABSTRACT

Neospora caninum is an apicomplexan parasite which has emerged as an important cause of bovine abortion worldwide. Abortion is usually triggered by reactivation of dormant bradyzoites during pregnancy and subsequent congenital infection of the foetus, where the central nervous system appears to be most frequently affected. We here report on an organotypic tissue culture model for Neospora infection which can be used to study certain aspects of the cerebral phase of neosporosis within the context of a three-dimensionally organised neuronal network. Organotypic slice cultures of rat cortical tissue were infected with N. caninum tachyzoites, and the kinetics of parasite proliferation, as well as the proliferation-inhibitory effect of interferon-gamma (IFN-gamma), were monitored by either immunofluorescence, transmission electron microscopy, and a quantitative PCR-assay using the LightCycler instrument, respectively. In addition, the neuronal cytoskeletal elements, namely glial acidic protein filaments as well as actin microfilament bundles were shown to be largely colocalising with the pseudocyst periphery. This organotypic culture model for cerebral neosporosis provides a system, which is useful to study the proliferation, ultrastructural characteristics, development, and the interactions of N. caninum within the context of neuronal tissue, which at the same time can be modulated and influenced under controlled conditions, and will be useful in the future to gain more information on the cerebral phase of neosporosis.


Subject(s)
Central Nervous System Parasitic Infections/parasitology , Cerebral Cortex/parasitology , Coccidiosis/parasitology , Neospora/growth & development , Neospora/pathogenicity , Animals , Cerebral Cortex/cytology , DNA, Protozoan/analysis , Fluorescent Antibody Technique , Host-Parasite Interactions , Interferon-gamma/pharmacology , Microscopy, Electron , Neospora/genetics , Neurons/parasitology , Organ Culture Techniques/methods , Polymerase Chain Reaction , Rats
5.
Neurobiol Dis ; 28(2): 175-83, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17706429

ABSTRACT

Inflammation of the subarachnoid and ventricular space contributes to the development of brain damage i.e. cortical necrosis and hippocampal apoptosis in pneumococcal meningitis (PM). Galectin-3 and -9 are known pro-inflammatory mediators and regulators of apoptosis. Here, the gene and protein expression profile for both galectins was assessed in the disease progression of PM. The mRNA of Lgals3 and Lgals9 increased continuously in the cortex and in the hippocampus from 22 h to 44 h after infection. At 44 h after infection, mRNA levels of Lgals9 in the hippocampus were 7-fold and those of Lgals3 were 30-fold higher than in uninfected controls (P<0.01). Galectin-9 protein did not change, but galectin-3 significantly increased in cortex and hippocampus with the duration of PM. Galectin-3 was localized to polymorphonuclear neutrophils, microglia, monocytes and macrophages, suggesting an involvement of galectin-3 in the neuroinflammatory processes leading to brain damage in PM.


Subject(s)
Brain/metabolism , Chemotaxis, Leukocyte/immunology , Encephalitis/metabolism , Galectin 3/metabolism , Galectins/metabolism , Meningitis, Pneumococcal/metabolism , Animals , Antigens, CD/immunology , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/immunology , Antigens, Differentiation, Myelomonocytic/metabolism , Biomarkers/analysis , Biomarkers/metabolism , Brain/immunology , Brain/microbiology , Cerebral Cortex/immunology , Cerebral Cortex/metabolism , Cerebral Cortex/microbiology , Chemotaxis, Leukocyte/genetics , Disease Models, Animal , Encephalitis/genetics , Encephalitis/microbiology , Galectin 3/genetics , Galectin 3/immunology , Galectins/genetics , Galectins/immunology , Hippocampus/immunology , Hippocampus/metabolism , Hippocampus/microbiology , Macrophages/immunology , Macrophages/metabolism , Meningitis, Pneumococcal/genetics , Meningitis, Pneumococcal/physiopathology , Microglia/immunology , Microglia/metabolism , Monocytes/immunology , Monocytes/metabolism , Nerve Degeneration/genetics , Nerve Degeneration/immunology , Nerve Degeneration/metabolism , Neutrophils/immunology , Neutrophils/metabolism , RNA, Messenger/metabolism , Rats , Up-Regulation/genetics , Up-Regulation/immunology
SELECTION OF CITATIONS
SEARCH DETAIL